BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 26, 2007
View Archived Issues
GPC Draws $10M Up Front In Japanese Marketing Deal
One month away from an FDA panel review, GPC Biotech Inc.'s satraplatin for prostate cancer has become the subject of a $10 million license deal with Yakult Honsha Co. Ltd., for rights in Japan. (BioWorld Today)
Read More
DPP-IV Inhibitor Data Abound As Januvia Competition Draws Near
Read More
Targeting Immunity, Not Invader, Key To Broad-Spectrum Antiviral
Read More
Argolyn Adds $16M In Series A For Peptide Drug Development
Read More
Other News To Note
Read More
Clinic Roundup
Read More